Pinto, B.; Novais, P.; Henriques, A.C.; Carvalho-Tavares, J.; Silva, P.M.A.; Bousbaa, H.
Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems. Pharmaceutics 2022, 14, 1209.
https://doi.org/10.3390/pharmaceutics14061209
AMA Style
Pinto B, Novais P, Henriques AC, Carvalho-Tavares J, Silva PMA, Bousbaa H.
Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems. Pharmaceutics. 2022; 14(6):1209.
https://doi.org/10.3390/pharmaceutics14061209
Chicago/Turabian Style
Pinto, Bárbara, Pedro Novais, Ana C. Henriques, Juliana Carvalho-Tavares, PatrÃcia M. A. Silva, and Hassan Bousbaa.
2022. "Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems" Pharmaceutics 14, no. 6: 1209.
https://doi.org/10.3390/pharmaceutics14061209
APA Style
Pinto, B., Novais, P., Henriques, A. C., Carvalho-Tavares, J., Silva, P. M. A., & Bousbaa, H.
(2022). Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems. Pharmaceutics, 14(6), 1209.
https://doi.org/10.3390/pharmaceutics14061209